Clinics in Dermatology
Volume 26, Issue 2 , Pages 182-191 , March 2008

Advanced botulinum toxin techniques against wrinkles in the upper face

  • Giovanni Salti, MD

      Affiliations

    • “Florence” Surgical Center, Florence, Italy
    • ,
  • Ilaria Ghersetich, MD

      Affiliations

    • Institute of Dermosciences, University of Florence, Florence, Italy
    • Corresponding Author InformationCorresponding author. Clinica Dermatologica, Villa Basilewski, via Lorenzo il Magnifico, 104, 50100 Firenze, Italy.

References 

  1. Carruthers A, Carruthers J. Treatment of glabellar furrows with botulinum A exotoxin. J Dermatol Surg Oncol. 1990;16:83
  2. Carruthers J, Carruthers A. Treatment of glabellar frown lines with C. botulinum A exotoxin. J Dermatol Surg Oncol. 1992;18:17–21
  3. Carruthers A, Carruthers J. History of the cosmetic use of botulinum A exotoxin. Dermatol Surg. 1998;24:1168–1170
  4. Blitzer A, Brin MF, Keen MF, et al. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg. 1993;119:1018–1022
  5. Lowe NJ, Maxwell A, Harper H. Botulinum A exotoxin for glabellar folds: a double blind, placebo-controlled study with electromyographic injection technique. J Am Acad Dermatol. 1996;24:1181–1183
  6. Spencer JM, Gordon M, Goldberg DJ. Botulinum B treatment of the glabellar and frontalis region: a dose-response analysis. J Cosmet Laser Ther. 2002;4:19–23
  7. Sadick NS. Botulinum toxin type B. Dermatol Surg. 2003;29:348–350
  8. Hambleton P. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use. J Neurol. 1992;239:16–20
  9. Brin MF. Botulinum toxin: chemistry, pharmacology, toxicity and immunology. Muscle Nerve Suppl. 1997;6:s146–s168
  10. Shaari CM, Sanders I. Assessment of the biological activity of botulinum toxin. In:  Jankovic J,  Hallet M editor. Therapy with botulinum toxin. New York, Basel, Hong Kong: Marcel Dekker; 1994;p. 159–172
  11. De Paiva A, Meunier FA, Molgo J, et al. Functional repair of motor end-plates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A. 1999;96:3200–3205
  12. Holds JB, Alderson K, Fogg SC, et al. Motor nerve sprouting in human orbicularis muscle after botulinum toxin A injection. Invest Ophtalmol Vis Sci. 1990;31:964–967
  13. Sommer B, Sattler G. Botulinum toxin in aesthetic medicine. Vienna - Berlin: Blackwell Science; 2001;
  14. Benedetto AV. The cosmetic uses of botulinum toxin type A. Int J Dermatol. 1999;38:641–655
  15. Klein AW. Dilution and storage of botulinum toxin. Dermatol Surg. 1998;24:1179–1180
  16. Trindade de Almeida AR, Kadunc BV, Di Chiacchio N, et al. Foam during reconstitution does not affect the potency of botulinum toxin type A. Dermatol Surg. 2003;29:530–532
  17. Redaelli A, Forte R. Botulinum toxin dilution: our technique. J Cosmet Laser Ther. 2003;5:218–219
  18. Carruthers J, Fagien S Matarasso SL & Botox Consensus Group. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg. 2004;112:1089–1098
  19. Le Louarn C. Botulinum toxin A and facial lines: the variable concentration. Aesthetic Plast Surg. 2001;25:73–84
  20. Hexsel D, De Almeida AT, Rutowotsch M, et al. Multicenter double blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application. Dermatol Surg. 2003;29:523–529
  21. Flynn TC, Carruthers A, Carruthers J. Surgical pearl: the use of Ultra-Fine II short needle 0.3 cc insulin syringe for botulinum toxin injections. J Am Acad Dermatol. 2002;46:931–933
  22. Vita G, Girlanda P, Puglisi RM, et al. Cardiovascular reflex testing and single fiber electromyography in botulism, A longitudinal study. Arch Neurol. 1987;44:202–206
  23. Claus D, Druschky A, Erbguth F. Botulinum toxin: influence on respiratory heart rate variation. Mov Disord. 1995;10:574–579
  24. Goschel H, Wohlfarth K, Frevert J, et al. Botulinum A toxin therapy: neutralizing and non neutralizing antibodies—therapeutic consequences. Exp Neurol. 1997;147:96–102
  25. Borodic G, Johnson E, Goodnough M, et al. Botulinum toxin therapy, immunologic resistance, and problems with the available materials. Neurology. 1996;46:26–29
  26. Greene P, Fahn S, Diaond B. Development of resistance to botulinum toxin A in patients with torticollis. Mov Disord. 1994;9:213–217
  27. Huang W, Rogachefsky AS, Foster AJ. Browlift with botulinum toxin. Dermatol Surg. 2000;26:55–60
  28. Huilgol SC, Carruthers A, Carruthers J. Raising eyebrows with botulinum toxin. Dermatol Surg. 1999;25:373–375
  29. Ozsoy Z, Gozu A, Genk B. Two-plane injection of botulinum exotoxin A in glabellar frown lines. Aesthetic Plast Surg. 2004;28:114–115
  30. Knize DM. Muscles that act on glabellar skin: a closer look. Plast Reconstr Surg. 2000;105:350–361
  31. Carruthers JDA, Carruthers A. Botulinum toxin and laser resurfacing for lines around the eyes. In:  Blitzer A,  Binder WJ,  Boyd JB, et al. editor. Management of facial lines and wrinkles. Philadelphia: Lippincott Williams & Wilkins; 2000;p. 315–332
  32. Salti G. Botulinum toxin for periocular lines: the single injection technique. J Cosmet Derm. 2004;3:122–125
  33. Alam M, Dover JS, Klein AW, et al. Botulinum a exotoxin for hyperfunctional facial lines: where not to inject. Arch Dermatol. 2002;138:118–1185
  34. Tamura BT. Standardization of muscle sites for BTX injection in the frontal and glabellar regions. In:  Hexsel D,  Trindade de Almeida A editor. Cosmetic use of botulinum toxin. Porto Alegre: AGE; 2002;

PII: S0738-081X(07)00192-7

doi: 10.1016/j.clindermatol.2007.09.008

Clinics in Dermatology
Volume 26, Issue 2 , Pages 182-191 , March 2008

Article Tools

* Image Usage & Resolution